col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

481 Results       Page 1

Elsevier: Medical Hypotheses
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―12 NIoBReTH: A novel integrative paradigm of protection against SARS-CoV-2 and other airborne pathogens with fewer socioeconomic constraints Qianxi Li, Yulin Ling, Guanxu Chen, Shangqiu Ye
2 [GO] 2024―Apr―30 Can SLU-PP-332 be a new drug to prevent COVID-19? B.-A. Hagiu
3 [GO] 2024―Apr―24 Determinants of long-lasting postviral COVID-19 and non-COVID-19 olfactory Dysfunction: The sanctuary theory Jerome R. Lechien
4 [GO] 2023―Oct―31 Long-term neurological implications of severe acute respiratory syndrome coronavirus 2 infections in neonates: Innate immune memory and chronic neuroinflammation Tatsuro Nobutoki
5 [GO] 2023―Oct―13 Brain fog in long COVID: A glutamatergic hypothesis with astrocyte dysfunction accounting for brain PET glucose hypometabolism Tatiana Horowitz, Luc Pellerin, Eduardo R. Zimmer, Eric Guedj
6 [GO] 2023―Oct―10 Molecular hydrogen as a potential adjuvant therapy for alleviating long COVID Nikola Todorovic, Sergej M. Ostojic
7 [GO] 2023―Mar―28 Will the increased use of ring lights during the coronavirus pandemic lead to a growing burden of macular degeneration? Jessica Stanhope, Philip Weinstein
8 [GO] 2023―Jan―27 Adipocytes in obesity: A perfect reservoir for SARS-CoV-2? JingJing Zhu, John P.H. Wilding, Ji Hu
9 [GO] 2022―Dec―16 Insulin may promote SARS-CoV-2 cell entry and replication in diabetes patients Wenwu Sun
10 [GO] 2022―Nov―18 Autophagy: A self-guard against SARS-CoV-2 Rafael Cardoso Maciel Costa Silva, Leonardo Holanda Travassos
11 [GO] 2022―Oct―27 Proposal for the use of an inhalation drug containing 2-5 oligoadenylates for treatment of COVID-19 Gernot Bruchelt, Jörn Treuner, Karlheinz Schmidt
12 [GO] 2022―Sep―21 Plasma fibrinogen: an important piece of the COVID-19 ICU delirium puzzle? Sarah Saxena, Alexandre-Raphael Wery, Adrian Khelif, Marie-Laure Nisolle, Christophe Lelubre, Mervyn Maze, et al. (+2)
13 [GO] 2022―Sep―17 Tailored lipopeptide surfactants as potentially effective drugs to treat SARS-CoV-2 infection Davoud Biria
14 [GO] 2022―Sep―09 COVID-19 diverse outcomes: aggravated reinfection, type I Interferons and antibodies Rafael Cardoso Maciel Costa Silva, Christianne Bandeira-Melo, Heitor Afonso Paula Neto, André Macedo Vale, Leonardo Holanda Travassos
15 [GO] 2022―Aug―03 Can plant-derived anti-HIV compounds be used in COVID-19 cases? Diptimayee Das, Atala Bihari Jena, Antara Banerjee, Arun Kumar Radhakrishnan, Asim K. Duttaroy, Surajit Pathak
16 [GO] 2022―Jul―01 An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic Ryszard Targoński, Aleksandra Gąsecka, Adrian Prowancki, Radosław Targoński
17 [GO] 2022―Jun―13 Can Covid-19 be iatrogenically auto-transmitted through Combined Oropharengeal and Nasopharengeal Swabs Test With One Bar? Hakan Alagozlu
18 [GO] 2022―Jun―08 WITHDRAWN: Elevated histamine etiology model for most major vaccine associated adverse events including SARS-CoV-2 spike vaccines Darrell O. Ricke
19 [GO] 2022―May―20 Multifaceted efficacy of caspofungin against fungal infections in COVID-19 patients Kazuhiro Itoh, Hiroshi Tsutani, Hiromichi Iwasaki
20 [GO] 2022―Apr―15 Deconditioning in COVID-19 survivors with reduced exercise performance: A role for endothelial dysfunction? Pasquale Ambrosino, Mauro Maniscalco
21 [GO] 2022―Apr―15 Are Dyskeratosis Congenita Patients at Higher Risk of Symptomatic COVID-19? Saeed Dorgaleleh, Karim Naghipoor, Amir Hozhabrpour, Hassan Vahidnezhad
22 [GO] 2022―Apr―13 Marginal BH4 Deficiencies, iNOS, and Self-perpetuating Oxidative Stress in Post-acute Sequelae of Covid-19 William A. Villaume
23 [GO] 2022―Feb―25 Proposal for assessment of the predominant symptom and physical function in patients suffering from Long COVID Cristina Roldán-Jiménez, Antonio Ignacio Cuesta-Vargas
24 [GO] 2022―Feb―23 Calcitonin gene-related peptide: A biomarker for stroke in SARS-CoV-2 infection? Yassamine Ouerdane, Yahia Khlidj, Mohamed S. Attia, Rafik Korissi
25 [GO] 2022―Feb―22 Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein Subhamoy Biswas, Sumanta Dey, Shreyans Chatterjee, Ashesh Nandy
26 [GO] 2022―Feb―22 Can COVID-19 vaccines relieve severe tension-type headache and migraine? Jordi González-Menacho, Mónica Villas-Roca, Helena Castañé, Jorge Joven, Jordi Camps, Simona Iftimie
27 [GO] 2022―Feb―22 Will the bone mineral density in postmenopausal women get worse during the COVID-19 pandemic? Yunzhong Cheng, Honghao Yang, Ziyang Liu, Yong Hai, Yuzeng Liu, Lijin Zhou
28 [GO] 2022―Feb―14 L-Methionine May Modulate the Assembly of SARS-CoV-2 by Interfering with the Mechanism of RNA Polymerase Maximo A. Benavides
29 [GO] 2022―Jan―25 Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis Carlos Eduardo Medina-De la Garza, Armando Salvador Flores-Torres, Marisela García-Hernández, María de los Ángeles Castro-Corona
30 [GO] 2022―Jan―25 Copper acetate aerosols: a possible tool complementary to vaccination in fight against SARS-CoV-2 and variants replication Deloncle Roger, Guillard Olivier, Pineau Alain, Lesage Gérard
31 [GO] 2022―Jan―25 Mitochondrial hijacking: a potential mechanism for SARS-CoV-2 to impair female fertility Jun Sun, Qiong Liu, Xinling Zhang, Shu Dun, Li Liu
32 [GO] 2022―Jan―04 A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients Pu-Yu Li, San-Qiang Li, She-Gan Gao, Dao-Yin Dong
33 [GO] 2022―Jan―04 Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment Hamendra Singh Parmar, Aakruti Nayak, Shreya Kataria, Versha Tripathi, Pooja Jaiswal, Pramod Kumar Gavel, et al. (+6)
34 [GO] 2022―Jan―03 Bioluminescence and Ventilator-Associated Pneumonia caused by oral biofilm in ICU during COVID-19 -Is there a possible relationship? Betsy Joseph, Liviu Steier
35 [GO] 2022―Jan―03 Nanomedicine formulations for respiratory infections by inhalation delivery: Covid-19 and beyond Oron Zachar
36 [GO] 2022―Jan―03 Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines Peter A. Feldman
37 [GO] 2022―Jan―03 SARS-CoV-2 might transmit through the skin while the skin barrier function could be the mediator Qiannan Xu, Li Zhang, Lihong Chen, Xiaoqing Zhao, Xiaopan Wang, Mengyan Hu, et al. (+4)
38 [GO] 2021―Dec―14 Nicotinic receptors as SARS-CoV-2 spike co-receptors? Valérian Dormoy, Jeanne-Marie Perotin, Philippe Gosset, Uwe Maskos, Myriam Polette, Gaëtan Deslée
39 [GO] 2021―Dec―09 Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension Jong Han Lee
40 [GO] 2021―Nov―09 BPC 157 as Potential Treatment for COVID-19 Sarah A. Deek
41 [GO] 2021―Nov―09 Vitamin D may prevent COVID-19 induced pregnancy complication Ali Al-Kaleel, Lubna Al-Gailani, Mustafa Demir, Hatice Aygün
42 [GO] 2021―Oct―29 Deregulated kynurenine metabolism - An alternate hypothesis for COVID-19 associated anosmia Amit Jain
43 [GO] 2021―Oct―29 Deficient synthesis of melatonin in COVID-19 can impair the resistance of coronavirus patients to mucormycosis Amarnath Sen
44 [GO] 2021―Oct―21 Are there medium to short-term effects of the airborne pollutant PM2.5 determining the emergence of SARS-CoV-2 variants? Yves Muscat Baron
45 [GO] 2021―Oct―14 Models for SARS-CoV-2 Associated Thrombocytopenia associated with Hemophagocytic Histiocytes Darrell O. Ricke
46 [GO] 2021―Oct―14 Molecular docking of SARS-COV-2 Spike epitope sequences identifies heterodimeric peptide-protein complex formation with human Zo-1, TLR8 and brain specific glial proteins Subhajit Dasgupta, Mausumi Bandyopadhyay
47 [GO] 2021―Oct―11 Moderate exercise may prevent the development of severe forms of COVID-19, whereas high-intensity exercise may result in the opposite BA. Hagiu
48 [GO] 2021―Sep―21 Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: potential therapeutic strategies Marian Simka
49 [GO] 2021―Sep―21 Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection Anubhuti Sood, Sreevatsan Raghavan, Puneet Batra, Karan Sharma, Aditya Talwar
50 [GO] 2021―Sep―15 Mucus targeting as a plausible approach to improve lung function in covid-19 patients Sarath S. Kumar, Aiswarya Binu, Aswathy.R. Devan, Lekshmi.R. Nath
51 [GO] 2021―Sep―13 Estimate of benefit attributable to wearing masks in chicago during the early days of the pandemic Damien G. Retzinger, Andrew C. Retzinger, Gregory S. Retzinger
52 [GO] 2021―Sep―09 High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection Pauline McDonagh Hull, Bonnie M. Lashewicz, Marvin J Fritzler
53 [GO] 2021―Sep―04 FUTHER COMMENT ON ARTICLES PERTAINING TO: “Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19 Anne Berbert
54 [GO] 2021―Aug―21 Nutrition acquisition by human immunity, transient overnutrition and the cytokine storm in severe cases of COVID-19 Boxuan Yu, Ligen Yu, Daniel J. Klionsky
55 [GO] 2021―Aug―10 Prolactin and susceptibility to COVID-19 infection Fatemeh Mirzaei, Alireza Tavilani, Zahra Asefy, Ebrahim Abbasi
56 [GO] 2021―Aug―09 Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study Ki Kwang Oh, Md. Adnan, Dong Ha Cho
57 [GO] 2021―Aug―05 The use of negative oxygen ion clusters [O2-(H2O)n] and bicarbonate ions [HCO3-] as the supportive treatment of COVID-19 infections: a possibility Ravindra V. Badhe, Sonali S. Nipate
58 [GO] 2021―Aug―05 Supportive therapy during COVID-19: the proposed mechanism of short-chain fatty acids to prevent cytokine storm and multi-organ failure M. Jardou, R. Lawson
59 [GO] 2021―Aug―03 Age, obesity and hyperglycaemia: Activation of innate immunity initiates a series of molecular interactions involving anionic surfaces leading to covid-19 morbidity and mortality Charles N. Birts, David C. Wilton
60 [GO] 2021―Jul―29 Barrier resuscitation by lay rescuers during COVID-19 pandemic Wolfgang Lederer, Markus Isser
61 [GO] 2021―Jul―06 TLR4 Involvement in COVID-19 Predicts a Seasonal Risk of Aspergillus Superinfection: A Call for Vigilance Andrew C. Retzinger, Gregory S. Retzinger
62 [GO] 2021―Jul―06 B cell receptor (BCR) guided Mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping Kabeer Haneef, Abdul Ghaffar Memon, Rabia Saleem, Farwa Batool, Mohd Sadeeq
63 [GO] 2021―Jul―06 Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? Ernesto Antonio Figueiro-Filho, Sebastian R. Hobson, Dan Farine, Mark H. Yudin
64 [GO] 2021―Jun―24 Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: a causal link? Luca Roncati, Greta Gianotti, Davide Gravina, Giovanna Attolini, Giuliana Zanelli, Norman Della Rosa, Roberto Adani
65 [GO] 2021―Jun―09 Diseased Lungs May Hinder COVID-19 Development: A Possible Reason for the Low Prevalence of COPD in COVID-19 Patients Shin Jie Yong
66 [GO] 2021―Jun―06 Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increaed severity of illness in COVID-19? Amarnath Sen
67 [GO] 2021―Jun―05 Early Multidrug Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents Paul E Alexander, Robin Armstrong, George Fareed, John Lotus, Ramin Oskoui, Chad Prodromos, et al. (+5)
68 [GO] 2021―Jun―04 Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia? Georges El Hasbani, Ali T Taher
69 [GO] 2021―Jun―01 A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine Demircan Ozbalci
70 [GO] 2021―May―20 Decorin as a possible strategy for the amelioration of COVID-19 Prince Allawadhi, Vishakha Singh, Isha Khurana, Pushkar Singh Rawat, Akshata Patangrao Renushe, Amit Khurana, et al. (+5)
71 [GO] 2021―May―12 Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19 Henry Sackin
72 [GO] 2021―May―12 Retraction notice to “Facemasks in the COVID-19 era: A health hypothesis” [Medical Hypotheses 146 (2021) 5] Baruch Vainshelboim
73 [GO] 2021―Apr―09 Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective Ahmed Yaqinuddin, Ayesha Rahman Ambia, Tasnim Atef Elgazzar, Maha bint Mishari AlSaud, Junaid Kashir
74 [GO] 2021―Mar―30 The Role of Carbohydrate Antigen 125 in COVID-19 Esra Dökümcü
75 [GO] 2021―Mar―30 Testicles, adipose organ and heart: a new axis in the management of SARS-CoV-2? Alexander Bertuccioli, Marco Cardinali, Francesco Di Pierro
76 [GO] 2021―Mar―30 Role of NLRP3 Inflammasome in COVID-19 and Periodontitis: Possible Protective Effect of Melatonin Ahmet Özer Şehirli, Umut Aksoy, Revan Birke Koca-Ünsal, Serkan Sayiner
77 [GO] 2021―Mar―25 Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients? Selma Rivas-Fuentes, Víctor Julián Valdés, Blanca Espinosa, Patricia Gorocica-Rosete, Alfonso Salgado-Aguayo
78 [GO] 2021―Mar―25 Strengthening CoViD-19 therapy via combinations of RAS modulators Veselina V. Uzunova, Angel Todev, Jacqueline Zarkos, Daniel Addai, Julian Ananiev, Pavel Rashev, et al. (+2)
79 [GO] 2021―Mar―23 Methylene blue: subduing the post COVID-19 blues! Rohan Magoon, Noopur Bansal, Armaanjeet Singh, Ramesh Kashav
80 [GO] 2021―Mar―23 Anticholinergic drugs versus preprocedural mouth rinses for reduction of SARS-CoV-2 load in dental aerosols Gargi S Sarode, Sachin C Sarode, Shankargouda Patil
81 [GO] 2021―Mar―23 Endotheliitis, Endothelin, and Endothelin Receptor Blockers in COVID-19 Devang K. Sanghavi, Anoop Titus, Thomas R. Caulfield, W. David Freeman
82 [GO] 2021―Mar―23 Are prion proteins and magnetite involved in the immune cells memory system connected to the covid-19? Fredrik C. Størmer
83 [GO] 2021―Mar―23 Aminoglycosides and their potential as SARS-CoV-2 antivirals Nevio Cimolai
84 [GO] 2021―Mar―07 Etoricoxib may inhibit cytokine storm to treat COVID-19 Ruo Wang
85 [GO] 2021―Feb―21 Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: is it scientifically justifiable? Hardeep Kaur, Phulen Sarma, Anusuya Bhattacharyya, Manisha Prajapat, Subodh Kumar, Ajay Prakash, Bikash Medhi
86 [GO] 2021―Feb―19 COVID-19, colchicine and glycemia Ioannis Ilias, Charalambos Milionis
87 [GO] 2021―Feb―19 Autism spectrum disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin Gregory M Brown, Ramanujam Karthikeyan, Seithikurippu R. Pandi-Perumal, Daniel P. Cardinali
88 [GO] 2021―Feb―19 COVID-19-related Arrhythmias and The Possible Effects of Ranolazine Ugochukwu Chukwunyere, Ahmet Ozer Sehirli, Nurettin Abacioglu
89 [GO] 2021―Feb―19 COVID-19: A Methyl-Group Assault? Andrew Mccaddon, Björn Regland
90 [GO] 2021―Feb―17 Persistent SARS-2 infections contribute to long COVID-19 John J.L. Jacobs
91 [GO] 2021―Feb―17 Old Drug, New Trick? The Rationale for the Treatment of COVID-19 with Activated Protein C Steven B. Pestka
92 [GO] 2021―Feb―15 Clofazimine: A Potential Therapeutic Option for Severe COVID-19 Areej Mohamed Ateya
93 [GO] 2021―Feb―15 Can bilirubin nanomedicine become a hope for the management of COVID-19? Isha Khurana, Prince Allawadhi, Amit Khurana, Amit Kumar Srivastava, Umashanker Navik, Anil Kumar Banothu, Kala Kumar Bharani
94 [GO] 2021―Feb―10 Pulmonary lipid modulation: a possible therapeutic target for SARS-CoV-2 infection Claudia Mandato, Pietro Vajro
95 [GO] 2021―Feb―09 A genetic insight into vitamin D binding protein and COVID-19 Mona Alshahawey
96 [GO] 2021―Jan―28 Airways to heaven: caution needed when exercising during COVID-19 Lucio Della Guardia, Roberto Codella
97 [GO] 2021―Jan―28 The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology Antoine Fakhry AbdelMassih, Rahma Menshawey, Rafeef Hozaien, Aya Kamel, Fady Mishriky, Reem J. Husseiny, et al. (+62)
98 [GO] 2021―Jan―24 Could diet and exercise reduce risk of COVID-19 syndemic? Walter M Chesnut, Scott MacDonald, Carlos Gustavo Wambier
99 [GO] 2021―Jan―24 Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19? Clara Gitahy Falcao Faria, Luisa Weiner, Julien Petrignet, Coraline Hingray, Ángel Ruiz De Pellon Santamaria, Bruno O. Villoutreix, et al. (+3)
100 [GO] 2021―Jan―24 SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome Josef Finsterer, Claudia Stöllberger
101 [GO] 2021―Jan―19 Daylight is critical to preserve 5-methoxytryptophol levels in suspected and confirmed COVID-19 patients Ahmet Özer Şehirli, Serkan Sayıner
102 [GO] 2021―Jan―11 Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rate Atanu Kumar Dutta, Kalyan Goswami
103 [GO] 2021―Jan―08 Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19 Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
104 [GO] 2021―Jan―08 Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4? Ciro Manzo, Jordi Serra-Mestres, Marco Isetta, Alberto Castagna
105 [GO] 2021―Jan―08 COVID-19 patients may become predisposed to pulmonary arterial hypertension Yuichiro J. Suzuki, Sofia I. Nikolaienko, Nataliia V. Shults, Sergiy G. Gychka
106 [GO] 2021―Jan―08 Platelet hyperactivity in COVID-19: Can the tomato extract fruitflow® be used as an antiplatelet regime? Niamh O'Kennedy, Asim K. Duttaroy
107 [GO] 2021―Jan―08 What sunspots are whispering about covid-19? Mariam M. Morchiladze, Tamila K. Silagadze, Zurab K. Silagadze
108 [GO] 2021―Jan―08 Polycations and polyanions in SARS-CoV-2 infection I. Ginsburg, E. Fibach
109 [GO] 2021―Jan―04 Looking beyond pulmonary disease in COVID-19: a lesson from patients with cystic fibrosis Sara Manti, Giuseppe Fabio Parisi, Maria Papale, Enza Mulè, Donatella Aloisio, Novella Rotolo, Salvatore Leonardi
110 [GO] 2021―Jan―02 COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Peter Wostyn
111 [GO] 2020―Dec―31 Will the COVID-19 pandemic increase the prevalence of idiopathic scoliosis? Ziyang Liu, Wenbo Jiang, Yong Hai, Yufu Liu, Tie Liu
112 [GO] 2020―Dec―31 Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy Seyed Aria Nejadghaderi, Ehsan Nazemalhosseini-Mojarad, Hamid Asadzadeh Aghdaei
113 [GO] 2020―Dec―30 Acute kidney injury due to COVID-19 and the circadian rhythm Merve Mercan, Ahmet Özer Şehirli, Ugochukwu Chukwunyere, Nurettin Abacıoğlu
114 [GO] 2020―Dec―26 Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients George D. Vavougios, Konstantinos T. Ntoskas, Triantafyllos K. Doskas
115 [GO] 2020―Dec―24 Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (covid-19) as well as other virus-induced “cytokines storm” Cesidio Giuliani, Ines Bucci, Giorgio Napolitano
116 [GO] 2020―Dec―23 Spa therapy (Balneotherapy) for rehabilitation of survivors of COVID-19 with persistent symptoms Sinan Kardeş
117 [GO] 2020―Dec―23 COVID-19/takotsubo/spontaneous coronary artery dissection: Lost in the Bermuda triangle John E. Madias
118 [GO] 2020―Dec―22 The Plausible Mechanisms of Tramadol for Treatment of COVID-19 Nahla E El-Ashmawy, Abdel-Halim A. Lashin, Kamal M. Okasha, Amal M. Abo Kamer, Tarek M. Mostafa, Mona El-Aasr, et al. (+4)
119 [GO] 2020―Dec―22 Reduction in the incidence of infectious diseases during the COVID-19 pandemic: A hypothesis Ashkan MohammadSadeghi
120 [GO] 2020―Dec―22 Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues… Ridhima Sharma, Rohan Magoon, Brajesh Kaushal
121 [GO] 2020―Dec―17 COVID-19 patients could be at high risk for dry socket Lakshmi Shetty, Shruti Nahar, Trivina Domah, A. Thirumal Raj
122 [GO] 2020―Dec―10 Methylene blue in covid-19 Giulio Scigliano, Giuseppe Augusto Scigliano
123 [GO] 2020―Dec―10 Ethnicity and the relationship between covid-19 and the herpes simplex viruses Peter Bond
124 [GO] 2020―Dec―09 Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19 Jelena Roganović
125 [GO] 2020―Dec―09 Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019? Fotios Barkas, Haralampos Milionis, Georgia Anastasiou, Evangelos Liberopoulos
126 [GO] 2020―Dec―09 Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection Lukasz Szarpak, Krzysztof Jerzy Filipiak, Aleksandra Gasecka, Michal Pruc, Anna Drozd, Milosz Jaroslaw Jaguszewski
127 [GO] 2020―Dec―04 Hypothesis: A Wearable Device May Help COVID-19 Patients Improve Lung Function Margaret L. Dow, Stephen R. Dugan
128 [GO] 2020―Nov―29 Inhaled Milrinone for sick COVID-19 cohort: a pathophysiology driven hypothesis! Rohan Magoon, Jasvinder Kaur Kohli, Ramesh Kashav
129 [GO] 2020―Nov―28 Does tetanus vaccination contribute to reduced severity of the COVID-19 infection? Christopher D. Rickett, Kristyn J. Maschhoff, Sreenivas R. Sukumar
130 [GO] 2020―Nov―28 Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster Andy Goren, Flavio Adsuara Cadegiani, Carlos Gustavo Wambier, Sergio Vano-Galvan, Antonella Tosti, Jerry Shapiro, et al. (+6)
131 [GO] 2020―Nov―28 Why does SARS-CoV-2 survive longer on plastic than on paper? Denis E. Corpet
132 [GO] 2020―Nov―27 Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols? Isabella N R Reis Reis INR, Guilherme Castro Lima Silva do Amaral Amaral GCLS, Aldrin André Huamán Mendoza Mendoza AAH, Yasmin Teixeira das Graças Graças YT, Maria Cássia Mendes-Correa Mendes-Correa MC, Giuseppe Alexandre Romito Romito GA, Claudio Mendes Pannuti Pannuti CM
133 [GO] 2020―Nov―26 Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19 Miroslaw Kiedrowski, Przemyslaw Kapala, Marlena Kiedrowska, Anna Skoczyńska, Aleksandra Czerw, Andrzej Deptała
134 [GO] 2020―Nov―25 Tackling the COVID-19 “cytokine storm” with microRNA mimics directly targeting the 3’UTR of pro-inflammatory mRNAs Jessica Gasparello, Alessia Finotti, Roberto Gambari
135 [GO] 2020―Nov―25 COVID-19 changes the lifestyle of the population and subtly reduces the incidence of metabolic disease Xianqiang Yu
136 [GO] 2020―Nov―25 COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics? Wim Van Damme, Ritwik Dahake, Remco van de Pas, Guido Vanham, Yibeltal Assefa
137 [GO] 2020―Nov―24 Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO2Life® (M101) Elise Lupon, Alexandre G. Lellouch, Franck Zal, Curtis L. Cetrulo, Laurent A. Lantieri
138 [GO] 2020―Nov―24 Is the oral cavity a reservoir for prolonged SARS-CoV-2 shedding? Matthias Troeltzsch, Ronald Berndt, Markus Troeltzsch
139 [GO] 2020―Nov―24 Passive Inhaled mRNA Vaccination for SARS-Cov-2: A Proposal Wee Song Yeo, Qin Xiang Ng
140 [GO] 2020―Nov―24 The firsrt psychiatric pandemic: Encephalitis lethargica, 1917-27 Edward Shorter
141 [GO] 2020―Nov―23 Alveolar epithelial cell type II could be the main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: a physio-pathological theory M. Carcaterra, C. Caruso
142 [GO] 2020―Nov―22 Facemasks in the COVID-19 era: A health hypothesis Baruch Vainshelboim
143 [GO] 2020―Nov―22 COVID-19: A double threat to takotsubo cardiomyopathy and spontaneous coronary artery dissection? Fahimehalsadat Shojaei, Zahra Habibi, Sogand Goudarzi, Fatemeh Dehghani Firouzabadi, Sahar Memar Montazerin, Homa Najafi, et al. (+8)
144 [GO] 2020―Nov―22 Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia? Gargi S. Sarode, Sachin C. Sarode, Amol R. Gadbail, Shailesh Gondivkar, Nilesh Kumar Sharma, Shankargouda Patil
145 [GO] 2020―Nov―21 Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution? Yves Muscat Baron
146 [GO] 2020―Nov―20 More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival Claire Hopkins, Jerome R. Lechien, Sven Saussez
147 [GO] 2020―Nov―20 Zinc supplementation for males during COVID-19: Is it beneficial ? Areej Mohamed Ateya, Nagwa A. Sabri
148 [GO] 2020―Nov―17 Development of Integrated Microfluidic Platform Coupled with Surface-Enhanced Raman Spectroscopy for Diagnosis of COVID-19 Siddhita Amit Jadhav, Pullithadathil. Biji, Manoj Kumar Panthalingal, Chilakapati Murali, Anjali Kulkarni, Sankaranarayanan Rajkumar, et al. (+2)
149 [GO] 2020―Nov―16 Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19 Francisco E Ramirez, Alberto Sanchez, Aki T Pirskanen
150 [GO] 2020―Nov―12 Hypothesis: alpha-1-antitrypsin is a promising treatment option for COVID-19 Xiyuan Bai, Joseph Hippensteel, Alida Leavitt, James P. Maloney, David Beckham, Cindy Garcia, et al. (+5)
151 [GO] 2020―Nov―12 SMOKING AND COVID-19, THE PARADOX TO DISCOVER:An Italian retrospective, observational study in hospitalized and non-hospitalized patients Carlo Lombardi, Elena Roca, Laura Ventura, Marcello Cottini
152 [GO] 2020―Nov―12 COVID-19’s toll on the elderly and those with diabetes mellitus - is vitamin B12 deficiency an accomplice? Andrew Kien Han Wee
153 [GO] 2020―Nov―11 Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D? Phuoc-Tan Diep
154 [GO] 2020―Nov―09 Dendritic Cell Vaccine Immunotherapy; the beginning of the end of Cancer and COVID-19. A Hypothesis Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz, Ahmed Abdellatif
155 [GO] 2020―Nov―08 Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 Mohamed Gargouri, Aboubaker Alzwi, Anis Abobaker
156 [GO] 2020―Nov―08 The ‘core’ of the ‘score’(COVID-19)? Rohan Magoon
157 [GO] 2020―Nov―08 Does yadgir population have copper-mediated intrinsic immunity to resist COVID-19 challenge? Shekar Patil, U.S. Vishal Rao, Gururaj Arakeri, Shankaragouda Patil, Peter A. Brennan
158 [GO] 2020―Nov―06 Blood clots in COVID-19 patients: Simplifying the curious mystery Saurav Biswas, Vikram Thakur, Parneet Kaur, Azhar Khan, Saurabh Kulshrestha, Pradeep Kumar
159 [GO] 2020―Nov―06 Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19? Noé Alvarado-Vasquez
160 [GO] 2020―Nov―06 SARS-CoV 2;Possible alternative virus receptors and pathophysiological determinants Leo Pruimboom
161 [GO] 2020―Nov―05 COVID-19 Inflammation Results in Urine Cytokine Elevation and Causes COVID-19 Associated Cystitis (CAC) Laura E. Lamb, Nivedita Dhar, Ryan Timar, Melissa Wills, Sorabh Dhar, Michael B. Chancellor
162 [GO] 2020―Nov―05 Inhaled route and anti-inflammatory action of ivermectin: do they hold promise in fighting against COVID-19? Niti Mittal, Rakesh Mittal
163 [GO] 2020―Nov―04 Should the convergence between the social and biological vulnerabilities of black communities and the COVID-19 pandemic be considered? Andrea Maria Narciso Rocha de Paula, Daniel Coelho, Claudia Luz de Oliveira, Ana Paula Venuto Moura
164 [GO] 2020―Nov―01 Periodontal pocket and COVID-19: Could there be a possible link? Nirupa Elisetti
165 [GO] 2020―Oct―23 May Interferon λ be a novel therapeutic approach against COVID-19? Azam Roohi, Pejman Soroosh
166 [GO] 2020―Oct―22 Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID-19 Morteza Ghasemnejad-Berenji, Sarvin Pashapour, Hojat Ghasemnejad-Berenji
167 [GO] 2020―Oct―21 A Multiple Therapy Hypothesis for Treatment of COVID-19 Patients Thomas P. Oscar
168 [GO] 2020―Oct―21 Ac2-26 Mimetic Peptide of Annexin A1 to treat severe COVID-19: a hypothesis Andre Gustavo Bonavita
169 [GO] 2020―Oct―09 The potential use of ABO blood group system for risk stratification of COVID-19 Antoine Fakhry AbdelMassih, Reham Mahrous, AbdelFattah Taha, Alaa Saud, Aliaa Osman, Bishoy Kamel, et al. (+26)
170 [GO] 2020―Oct―08 Pro resolving inflammatory effects of the lipid mediators of Omega 3 fatty acids and its implication in SARS COVID-19 Pedro-Antonio Regidor, Fernando Gonzalez Santos, Jose Miguel Rizo, Fernando Moreno Egea
171 [GO] 2020―Oct―08 NCAM protein and SARS-COV-2 surface proteins: in-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré Syndrome Sara Morsy
172 [GO] 2020―Oct―07 COMMENT ON AN ARTICLE: ,High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia“ Omer Ć. Ibrahimagić, Suljo Kunić
173 [GO] 2020―Oct―07 Is a COVID-19 vaccine developed by nature already at work? Nilesh Kumar Sharma, Sachin C. Sarode, Gargi Sarode, Shankargouda Patil
174 [GO] 2020―Oct―06 COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway Farrukh Ahmad
175 [GO] 2020―Oct―06 Dysimmunity and inflammatory storm: Watch out for bone lesions in COVID-19 infection Huaqiang Tao, Gaoran Ge, Wenming Li, Xiaolong Liang, Hongzhi Wang, Ning Li, et al. (+3)
176 [GO] 2020―Oct―05 A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections Ba X. Hoang, Bo Han
177 [GO] 2020―Oct―01 Hypothesis: Oxytocin Is A Direct COVID-19 Antiviral Phuoc-Tan Diep, Khojasta Talash, Violet Kasabri
178 [GO] 2020―Oct―01 Falls in older adults: the new pandemic in the post COVID-19 era? Miguel Ángel De La Cámara
179 [GO] 2020―Oct―01 Viral replication of SARS-CoV-2 could be self-limitative - the role of the renin-angiotensin system on COVID-19 pathophysiology Vinicius Novaes Rocha
180 [GO] 2020―Sep―30 SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients Ashutosh Kumar, Ravi K. Narayan, Chiman Kumari, Muneeb A. Faiq, Maheswari Kulandhasamy, Kamla Kant, Vikas Pareek
181 [GO] 2020―Sep―29 COVID-19, Myocardial Edema and Dexamethasone Moezedin Javad Rafiee, Faranak Babaki Fard, Matthias G. Friedrich
182 [GO] 2020―Sep―28 COVID-19 in children: could pertussis vaccine play the protective role? Mohamad Bachar Ismail, Sarah Al Omari, Rayane Rafei, Fouad Dabboussi, Monzer Hamze
183 [GO] 2020―Sep―28 Chronic Exposure to Air Pollution Implications on COVID-19 Severity Sarah A. Deek
184 [GO] 2020―Sep―25 The “COVID-19 Score” can predict the need for tracheal intubation in critically ill COVID-19 patients - A hypothesis Ankur Khandelwal, Gyaninder Pal Singh, Girija Prasad Rath, Arvind Chaturvedi
185 [GO] 2020―Sep―24 Factors related to asymptomatic or severe COVID-19 infection Eduardo Pérez-Campos Mayoral, María Teresa Hernández-Huerta, Laura Pérez-Campos Mayoral, Carlos Alberto Matias-Cervantes, Gabriel Mayoral-Andrade, Luis Ángel Laguna Barrios, Eduardo Pérez-Campos
186 [GO] 2020―Sep―24 Potential Role of GcMAF in suppressing the severity of COVID-19-induced immune responses: lesson learned from HIV Lucrezia Spadera, Maria Spadera
187 [GO] 2020―Sep―19 Should an intersection between visceral leishmaniasis endemicity and the COVID-19 pandemic be considered? Sílvio Fernando Guimarães Carvalho, Thallyta Maria Vieira, Ana Paula Venuto Moura, Marileia Chaves Andrade
188 [GO] 2020―Sep―19 Aerosol anguish in dentistry in COVID-19 pandemic: A hypotheses or reality? Harneet Kaur, Anuraj Singh Kochhar
189 [GO] 2020―Sep―18 The paradoxical effect of IL-6 and implications for the use of Tocilizumab in Covid-19 patients Vincenzo Bruzzese, Antonio Ivan Lazzarino
190 [GO] 2020―Sep―17 Smart polymeric eye gear: A possible preventive measure against ocular transmission of COVID-19 Dipak Kumar Sahu, Deepak Pradhan, Pradeep Kumar Naik, Biswakanth Kar, Goutam Ghosh, Goutam Rath
191 [GO] 2020―Sep―17 Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis R.C. Reisin, P. Rozenfeld, P. Bonardo
192 [GO] 2020―Sep―17 Do not call it COVID-19, it might have been the second wave Frank Rühli, Patrick Eppenberger, Maciej Henneberg
193 [GO] 2020―Sep―17 Role of testosterone in COVID-19 patients - A double-edged sword? Aneela N. Hussain, Fazal Hussain, Shahrukh K. Hashmi
194 [GO] 2020―Sep―17 Obesity, abdominal organ size and COVID-19 severity Lina Zabuliene, Ioannis Ilias
195 [GO] 2020―Sep―17 Host - virus - drug interactions as determinants of COVID-19’s phenotypes: A data-driven hypothesis George D. Vavougios
196 [GO] 2020―Sep―16 Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19 Nunzio Pomara, Bruno P. Imbimbo
197 [GO] 2020―Sep―16 Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era Ismo T. Räisänen, Kehinde A. Umeizudike, Pirjo Pärnänen, Pia Heikkilä, Taina Tervahartiala, Solomon O. Nwhator, et al. (+3)
198 [GO] 2020―Sep―16 Alcohol consumption and obesity: The hidden scare with COVID-19 severity Bushra Bilal, Faizan Saleem, Syeda Sadia Fatima
199 [GO] 2020―Sep―16 Phosphatidylglycerol and surfactant: A potential treatment for COVID-19? Wendy B. Bollag, Joyce N. Gonzales
200 [GO] 2020―Sep―16 A hypothesis for examining dihydroxyacetone, the active component in sunless tanning products, as a topical prophylactic against SARS-COV-2 transmission David M. Perrin
201 [GO] 2020―Sep―13 Is there an under-representation of skin of colour images during the COVID-19 outbreak? Nicolas Kluger, Mahtab Samimi
202 [GO] 2020―Sep―13 Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients Ashutosh Kumar, Muneeb A. Faiq, Vikas Pareek, Khursheed Raza, Ravi K. Narayan, Pranav Prasoon, et al. (+8)
203 [GO] 2020―Sep―12 Empiric Antibiotics in Management of Inpatient Pregnant Women Infected with Coronavirus Disease 2019 (COVID-19): Focusing on Inflammation and Preterm Labor Amir Hossein Norooznezhad, Sedigheh Hantoushzadeh, Alireza A. Shamshirsaz
204 [GO] 2020―Sep―11 Considerations on the article De Bernardis, E., & Busà, L. (2020). A putative role for the tobacco mosaic virus in smokers’ resistance to COVID-19 Medical Hypotheses, 110153 Vincenzo Zagà, Daniel L. Amram, Giacomo Mangiaracina, Maria Sofia Cattaruzza
205 [GO] 2020―Sep―11 The viral protein fragment theory of COVID-19 pathogenesis Yuichiro J. Suzuki
206 [GO] 2020―Sep―10 Potential of electric stimulation for the management of COVID-19 Prince Allawadhi, Amit Khurana, Sachin Allwadhi, Uma Shanker Navik, Kamaldeep Joshi, Anil Kumar Banothu, Kala Kumar Bharani
207 [GO] 2020―Sep―10 Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis Meenu Mehta, Parteek Prasher, Mousmee Sharma, Madhur D Shastri, Navneet Khurana, Manish Vyas, et al. (+6)
208 [GO] 2020―Sep―10 Washing Hands and the Face May Reduce COVID-19 Infection Andrzej Przekwas, Zhijian Chen
209 [GO] 2020―Sep―10 COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome Aziz Rodan Sarohan
210 [GO] 2020―Sep―09 Distinguishing between Typical Kawasaki Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Wee-Song Yeo, Qin Xiang Ng
211 [GO] 2020―Sep―09 Role of inositol to improve surfactant functions and reduce IL-6 levels: a potential adjuvant strategy for SARS-CoV-2 pneumonia? Antonio Simone Laganà, Vittorio Unfer, Simone Garzon, Mariano Bizzarri
212 [GO] 2020―Sep―04 Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 Disease Yaron Niv
213 [GO] 2020―Sep―04 SARS-CoV-2 and miRNA-like inhibition power Jacques Demongeot, Hervé Seligmann
214 [GO] 2020―Sep―03 Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome Maxime Rossi, Michael Piagnerelli, Alain Van Meerhaeghe, Karim Zouaoui Boudjeltia
215 [GO] 2020―Sep―03 COVID-19 and the renin-angiotensin system (RAS): a spark that sets the forest alight? O.J. Wiese, B.W. Allwood, A.E. Zemlin
216 [GO] 2020―Sep―03 Can roflumilast become steroid-sparing alternative in the treatment of COVID-19? Chirag A Shah
217 [GO] 2020―Sep―03 A role of glycation and methylation for SARS-CoV-2 infection in diabetes? Giovanni Sartore, Eugenio Ragazzi, Luca Faccin, Annunziata Lapolla
218 [GO] 2020―Sep―02 Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19 Jodi D. Stookey, Prasanna K.R. Allu, Dorothee Chabas, David Pearce, Florian Lang
219 [GO] 2020―Sep―02 Hypothesis: Nasal vs. oral inhalation accounts for the severity of COVID-19 Barry R. Komisaruk
220 [GO] 2020―Sep―02 Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? Matthias Karst, Josef Hollenhorst, Johannes Achenbach
221 [GO] 2020―Sep―02 Ketonuria with or without ketoacidosis as the presenting manifestation of SARS-CoV-2 (COVID-19) among uncontrolled Type 2 Diabetic patients Mohamed H Emara, Usama Mazid, Mohamed Ali Atta, Sahar Elshahat, Aya Mohamed Mahros
222 [GO] 2020―Sep―02 Second wave of Covid-19 is determined by immune mechanism Osama Hussein
223 [GO] 2020―Sep―02 McGurk effect and audiovisual speech perception in students with learning disabilities exposed to online teaching during the COVID-19 pandemic Elena Kkese
224 [GO] 2020―Sep―02 Olfactory dysfunction may predict myocardial injury in COVID-19 patients Ercan Akşit, Özge Çağlar Çil, Hakkı Kaya
225 [GO] 2020―Sep―02 Non-Invasive Assessment of Endothelial Dysfunction: A novel method to predict severe COVID-19? Sarangini Yoganandamoorthy, M.A.D.S.N. Munasinghe, L.V.U. Wanigasuriya, M.K.K. Priyankara, Saroj Jayasinghe
226 [GO] 2020―Sep―02 Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route Ana Patrícia de Oliveira, André Luis Fernandes Lopes, Gabriella Pacheco, Isabela Ribeiro de Sá Guimarães Nolêto, Lucas Antonio Duarte Nicolau, Jand Venes Rolim Medeiros
227 [GO] 2020―Sep―02 Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities Sean M. Hacking
228 [GO] 2020―Aug―30 Can Hyperbaric Oxygen safely serve as an anti-inflammatory treatment for COVID-19? Anders Kjellberg, Antonio De Maio, Peter Lindholm
229 [GO] 2020―Aug―27 COVID-19 and ethnicity: does reduced responsiveness to glucocorticoids explain the more aggressive nature of disease among minorities? Abhinav Karan, Kabeer Ali, Kirin Rambaran, Pedro Del Corral, Sateesh Sakhamuri, Surujpal Teelucksingh
230 [GO] 2020―Aug―26 Role of Latent Tuberculosis Infections in Reduced COVID-19 Mortality: Evidence from an Instrumental Variable Method Analysis Harutaka Takahashi
231 [GO] 2020―Aug―26 SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: a primer of neurodegeneration George D. Vavougios
232 [GO] 2020―Aug―26 SARS-CoV-2-mediated encephalitis: role of AT2R receptors in the blood-brain barrier Antônio Kleiton de Sousa, Diva de Aguiar Magalhães, Jayro dos Santos Ferreira, André Luiz dos Reis Barbosa
233 [GO] 2020―Aug―25 Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity Rob Janssen, Jona Walk
234 [GO] 2020―Aug―24 Nasal lavage containing Angiotensin- Converting Enzyme -2 agonist can prevent and reduce viral load in COVID-19 Gaelle Vofo, Ronit Brodie, Menachem Gross
235 [GO] 2020―Aug―24 Repurposing Prolactin as a Promising Immunomodulator for the Treatment of COVID-19: Are Common Antiemetics the Wonder Drug to Fight Coronavirus? Amarnath Sen
236 [GO] 2020―Aug―24 COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis? Marileia Chaves Andrade, Rodolfo Souza de Faria, Sergio Avelino Mota Nobre
237 [GO] 2020―Aug―19 A new approach for COVID-19 treatment by micro-RNA Sobhy Hassab El-Nabi, Mohamed Elhiti, Mostafa El-Sheekh
238 [GO] 2020―Aug―18 Could Imiquimod (5% Aldara) or Other TLR7 Agonists be Used in The Treatment of COVID-19? Huseyin Avcilar, Ahmet Eken
239 [GO] 2020―Aug―17 It is Time To Drop Hydroxychloroquine From our COVID-19 Armamentarium Tarek Kashour, Imad M. Tleyjeh
240 [GO] 2020―Aug―17 Household representative sample strategy for COVID-19 large-scale population screening John Takyi-Williams
241 [GO] 2020―Aug―17 Exercise as medicine for COVID-19: on PPAR with emerging pharmacotherapy Kevin S. Heffernan, Sushant Ranadive, Sae Young Jae
242 [GO] 2020―Aug―15 The AI-discovered Aetiology of COVID-19 and Rationale of the Irinotecan+ Etoposide Combination Therapy for Criti- cally Ill COVID-19 Patients Bragi Lovetrue
243 [GO] 2020―Aug―14 Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection Erkan Cure, Medine Cumhur Cure
244 [GO] 2020―Aug―14 A potential therapeutic combination for treatment of COVID-19: synergistic effect of DPP4 and RAAS suppression Phyu Phyu Khin, Seon-Heui Cha, Hee-Sook Jun, Jong Han Lee
245 [GO] 2020―Aug―10 Bone biology and COVID-19 infection: Is ACE2 a potential influence factor? Huaqiang Tao, Jiaxiang Bai, Weicheng Zhang, Kai Zheng, Pengfei Guan, Gaoran Ge, et al. (+2)
246 [GO] 2020―Aug―10 SCan Charcoal Improve Outcomes in COVID-19 Infections? Zeid J. Khitan, Imran Khawaja, Maurice A. Mufson, Juan R. Sanabria, Nader G. Abraham, Stephen J. Peterson, et al. (+2)
247 [GO] 2020―Aug―10 Infection-iron interaction during COVID-19 pandemic: time to re-design iron supplementation programs Little Flower Augustine, Vydehi Mullapudi, Sadhana Subramanyan, Bharati Kulkarni
248 [GO] 2020―Aug―07 IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19 José J. Leija-Martínez, Fengyang Huang, Blanca E. Del-Río-Navarro, Fausto Sanchéz-Muñoz, Onofre Muñoz-Hernández, Abraham Giacoman-Martínez, et al. (+2)
249 [GO] 2020―Aug―07 Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14 Simon H Murch
250 [GO] 2020―Aug―07 Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome? Bryan J. Winn
251 [GO] 2020―Aug―05 Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19 Lichen Ouyang, Jie Gong
252 [GO] 2020―Aug―05 Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation Naoki Yamamoto, Georg Bauer
253 [GO] 2020―Aug―05 SARS-CoV-2 infection and impact on female genital tract: An untested hypothesis Eleftherios Vavoulidis, Chrysoula Margioula-Siarkou, Stamatios Petousis, Konstantinos Dinas
254 [GO] 2020―Aug―05 Air conditioning system usage and SARS-CoV-2 Transmission dynamics in Iran Mahmoud Reza Pourkarim, Marijn Thijssen, Philippe Lemey, Anne-Mieke Vandamme, Marc Van Ranst
255 [GO] 2020―Aug―02 The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions José Caetano Silva-Filho, Cynthia Germoglio Farias de Melo, Janaína Lima de Oliveira
256 [GO] 2020―Jul―31 A putative role for the tobacco mosaic virus in smokers’ resistance to COVID-19 E. de Bernardis, L. Busà
257 [GO] 2020―Jul―31 Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content Fatma Beyazit, Yavuz Beyazit, Alpaslan Tanoglu, Ibrahim C. Haznedaroglu
258 [GO] 2020―Jul―31 The importance of cell-mediated immunity in COVID-19-An opinion Henna Iqbal
259 [GO] 2020―Jul―31 Why do children seem to be more protected against COVID-19? A hypothesis Bruno Sposato, Marco Scalese
260 [GO] 2020―Jul―30 Estrogen shields women from COVID-19 complications by reducing ER stress Sana Shabbir, Assad Hafeez, Muhammad Arshad Rafiq, Muhammad Jawad Khan
261 [GO] 2020―Jul―29 Are night shift workers at an increased risk for COVID-19? Rachel K. Lim, Carlos G. Wambier, Andy Goren
262 [GO] 2020―Jul―26 Environmental pollutant exposure can exacerbate COVID-19 neurologic symptoms Michael Sigfrid S. Reyes, Paul Mark B. Medina
263 [GO] 2020―Jul―26 High dose folic acid is a potential treatment for Pulmonary Hypertension, including when associated with COVID-19 pneumonia Esko Wiltshire, Alexia Sophie Peña, Karen MacKenzie, Geoffrey Shaw, Jennifer Couper
264 [GO] 2020―Jul―26 The Possible Immunoregulatory and Anti-Inflammatory Effects of Selective Serotonin Reuptake Inhibitors in Coronavirus Disease Patients Mohammed Gaber Mohamed Hamed, Radwa Samir Hagag
265 [GO] 2020―Jul―25 Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19 Alain Townsend
266 [GO] 2020―Jul―25 Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution? William Gustavo Lima, Júlio César Moreira de Brito, Waleska Stephanie da Cruz Nizer
267 [GO] 2020―Jul―24 N-acetycysteine: a potential therapeutic agent in COVID-19 infection N Jaiswal, M Bhatnagar, H Shah
268 [GO] 2020―Jul―22 Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity Martin Balzan
269 [GO] 2020―Jul―22 The war against the SARS-CoV2 infection: is it better to fight or mitigate it? Fabrizio Dal Moro, Igor Vendramin, Ugolino Livi
270 [GO] 2020―Jul―21 Possible Mechanisms Responsible for Acute Coronary Events in COVID-19 Aakash R Sheth, Udhayvir S Grewal, Harsh P Patel, Samarthkumar Thakkar, Subhash Garikipati, Jashwanth Gaddam, Danish Bawa
271 [GO] 2020―Jul―21 Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 Karsten Buschard
272 [GO] 2020―Jul―21 Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease Ajay Gupta, Kate Chander Chiang
273 [GO] 2020―Jul―21 ‘The Double-Edged Sword’ - An Hypothesis For Covid-19-Induced Salivary Biomarkers John Adeoye, Peter Thomson
274 [GO] 2020―Jul―21 Acute Respiratory Distress Syndrome from Covid-19: a perfect storm from free radicals? Proposal for a new treatment Giulio Scigliano, Giuseppe Augusto Scigliano
275 [GO] 2020―Jul―21 Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: reasoning about connections Giampaolo Minetti
276 [GO] 2020―Jul―18 Kawasaki-like disease in children with COVID-19: A hypothesis Hamideh Amirfakhryan
277 [GO] 2020―Jul―18 Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence Ravi Philip Rajkumar
278 [GO] 2020―Jul―18 Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome Gregor A. Bara, Dirk de Ridder, Jaroslaw Maciaczyk
279 [GO] 2020―Jul―16 Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS) Flavio A. Cadegiani, Andy Goren, Carlos G. Wambier
280 [GO] 2020―Jul―15 Inhaled Hydroxychloroquine to Improve Efficacy and Reduce Harm in the Treatment of COVID-19 Oisín Kavanagh, Anne Marie Healy, Francis Dayton, Shane Robinson, Niall J. O'Reilly, Brian Mahoney, et al. (+3)
281 [GO] 2020―Jul―15 Inflammation: A bridge between Diabetes and COVID-19, and possible management with sitagliptin Negin Mozafari, Soha Azadi, Sanaz Mehdi-Alamdarlou, Hajar Ashrafi, Amir Azadi
282 [GO] 2020―Jul―15 COMMENT ON AN ARTICLE: “Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19 Omer Ć. Ibrahimagić, Dževdet Smajlović, Zikrija Dostović, Mirjana Vidović, Emir Tupković, Suljo Kunić
283 [GO] 2020―Jul―15 BCG vaccination and COVID-19: Much ado about nothing? M. Caminati, F. Furci, G. Senna, G. Delfino, A. Poli, C. Bovo, V. Patella
284 [GO] 2020―Jul―14 Recombinant Protein Targeting and Opsonizing Spike Glycoprotein for Enhancing SARS-CoV-2 Phagocytosis Latifa Khattabi
285 [GO] 2020―Jul―13 The immunomodulatory effects of exercise against COVID-19 Roberto Codella
286 [GO] 2020―Jul―13 SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression Rubens Cecchini, Alessandra Lourenço Cecchini
287 [GO] 2020―Jul―12 Platelets to surrogate lung inflammation in COVID-19 Patients Haripriya Kuchi Bhotla, Tanushri Kaulb, Balamuralikrishnan Balasubramanian, Murugesh Easwaran, Vijaya Anand Arumugam, Manikantan Pappusamy, et al. (+2)
288 [GO] 2020―Jul―12 Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection Andrea Belluzzi, Eleonora Scaioli, Luigi Ricciardiello, Giovanni Marasco, Carlotta Belluzzi
289 [GO] 2020―Jul―10 The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy Sun Jun
290 [GO] 2020―Jul―09 The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19 Luca Roncati, Beatrice Lusenti
291 [GO] 2020―Jul―09 Does COVID-19 cause permanent damage to olfactory and gustatory function? Gamba Paolo
292 [GO] 2020―Jul―09 COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection Hulya Vatansev, Cengiz Kadiyoran, Medine Cumhur Cure, Erkan Cure
293 [GO] 2020―Jul―09 EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: novel propositions Saranya Varadarajan, Thodur Madapusi Balaji, Sachin C. Sarode, Gargi S. Sarode, Nilesh K. Sharma, Shailesh Gondivkar, et al. (+2)
294 [GO] 2020―Jul―09 Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate Rituparna Acharya
295 [GO] 2020―Jul―08 Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduce the death toll Shakeel Shazad, Mark Willcox
296 [GO] 2020―Jul―07 Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution Néstor H. García, Daniela J. Porta, Roxana V. Alasino, Sonia E. Muñoz, Dante M. Beltramo
297 [GO] 2020―Jul―07 The Mortality and Psychological Burden Caused by Response to COVID-19 Outbreak: a Hypothesis and a Crude Estimation Erlangga Yusuf, Anna Tisler
298 [GO] 2020―Jul―07 Surfactant-based prophylaxis and therapy against COVID-19: A possibility K. Pramod, Sabna Kotta, U.S. Jijith, A. Aravind, M. Abu Tahir, C.S. Manju, H.V. Gangadharappa
299 [GO] 2020―Jul―03 Transpulmonary Electrotherapy for Reduction of Lung Viral Load of SARS-CoV-2 in Patients with COVID-19 Nickolas Kipshidze, Valeri S. Chekanov, Nodar Kipshidze, Vivek Reddy, George Dangas
300 [GO] 2020―Jul―03 Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer? Shao-Lin Tao, Xue-mei Wang, Yong-geng Feng, Po-ming Kang, Qing-yuan Li, Tian-yu Sun, et al. (+2)
301 [GO] 2020―Jul―03 Is Macrophages Heterogeneity Important in Determining Covid-19 Lethality? Pasquale Pagliaro
302 [GO] 2020―Jul―03 COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming ?” Pierre DENIS
303 [GO] 2020―Jul―02 Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection Lise Lund Håheim
304 [GO] 2020―Jul―02 Factors involved in low susceptibility to COVID-19: An adaptation of high altitude inhabitants Celia Choquenaira-Quispe, Vanessa Saldaña-Bobadilla, J. Kenedy Ramirez
305 [GO] 2020―Jul―02 Harnessing Adenosine A2A Receptors as a Strategy for Suppressing the Lung Inflammation and Thrombotic Complications of COVID-19: Potential of Pentoxifylline and Dipyridamole James J. DiNicolantonio, Jorge Barroso-Aranda
306 [GO] 2020―Jul―01 A hypothesis on the role of the human immune system in covid-19 Hind Khairi Khashkhosha, Muhammed Elhadi
307 [GO] 2020―Jul―01 Have the symptoms of patients with COVID-19 changed over time during hospitalization? Fatemeh Dehghani Firouzabadi, Mohammad Dehghani Firouzabadi, Babak Ghalehbaghi, Hesam Jahandideh, Maryam Roomiani, Sogand Goudarzi
308 [GO] 2020―Jul―01 SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor Rosario Foti, Giorgio Amato, Visalli Elisa
309 [GO] 2020―Jun―30 Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities Ahmed Yaqinuddin
310 [GO] 2020―Jun―29 COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity R. Miller, A.R. Wentzel, G. Richards
311 [GO] 2020―Jun―28 Reposition of Montelukast either alone or in combination with Levocetirizine against SARS-CoV-2 Dipankar Bhattacharyya
312 [GO] 2020―Jun―27 Rethinking interleukin-6 blockade for treatment of COVID-19 S. Scherger, A. Henao Martinez, C. Franco-Paredes, L. Shapiro
313 [GO] 2020―Jun―27 Into the looking glass: Post-viral syndrome post COVID-19 Ray Perrin, Lisa Riste, Mark Hann, Andreas Walther, Annice Mukherjee, Adrian Heald
314 [GO] 2020―Jun―27 Can volcanic trace elements facilitate Covid-19 diffusion? A hypothesis stemming from the Mount Etna area, Sicily Loredana Raciti, Rocco Salvatore Calabrò
315 [GO] 2020―Jun―27 Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets Anurag Kumar Singh, Gaurav Mishra, Anand Maurya, Giriraj T. Kulkarni, Rajendra Awasthi
316 [GO] 2020―Jun―27 Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2 Edoardo Francini, Salvatora T. Miano, Anna I. Fiaschi, Guido Francini
317 [GO] 2020―Jun―26 Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease Daniel P. Cashman
318 [GO] 2020―Jun―26 Cytochrome P450-mediated drug interactions in COVID-19 patients: current findings and possible mechanisms Mahmoud A. El-Ghiaty, Sherif M. Shoieb, Ayman O.S. El-Kadi
319 [GO] 2020―Jun―25 Will an obesity pandemic replace the coronavirus disease-2019 (COVID-19) pandemic? Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
320 [GO] 2020―Jun―25 Coronavirus disease 2019 (COVID 19) and Malaria. Have anti glycoprotein antibodies a role? Aurora Parodi, Emanuele Cozzani
321 [GO] 2020―Jun―25 SARS-CoV-2 and the sympathetic immune response: dampening inflammation with antihypertensive drugs (Clonidine and Propranolol) Sanjiv K Hyoju, Olga Zaborina, Harry van Goor
322 [GO] 2020―Jun―24 rAre graphene and graphene-derived products capable of preventing COVID-19 infection? Pawan Kumar Raghav, Sujata Mohanty
323 [GO] 2020―Jun―23 COVID-19 as a Viral Functional ACE2 Deficiency Disorder with ACE2 Related Multi-organ Disease Rosemary Gan, Nicholas P. Rosoman, David J.E. Henshaw, Euan P. Noble, Peter Georgius, Nigel Sommerfeld
324 [GO] 2020―Jun―23 Hypoxemia IN COVID-19 Patients: An Hypothesis H.K. Fisher
325 [GO] 2020―Jun―23 Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances Hervé Javelot, Julien Petrignet, Frédéric Addiego, Jeanne Briet, Morgane Solis, Wissam El-Hage, et al. (+2)
326 [GO] 2020―Jun―23 Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis Mathieu Uzzan, Olivier Corcos, Jerome C. Martin, Xavier Treton, Yoram Bouhnik
327 [GO] 2020―Jun―21 Prognostic role of nutritional status in elderly patients hospitalized for COVID-19 Guerino Recinella, Giovanni Marasco, Antonia Di Battista, Giampaolo Bianchi, Marco Zoli
328 [GO] 2020―Jun―21 Is it Possible to Use Proton Pump Inhibitors in COVID-19 Treatment and Prophylaxis? Şeyma Taştemur, Hilmi Ataseven
329 [GO] 2020―Jun―21 Pulmonary surfactant itself must be a strong defender against SARS-CoV-2 Hideyuki Takano
330 [GO] 2020―Jun―20 Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19 NandhaKumar Sathyamoorthy, Pavan Kumar Chintamaneni, Santhivardhan Chinni
331 [GO] 2020―Jun―20 Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): gender and age influences Guglielmina Froldi, Paola Dorigo
332 [GO] 2020―Jun―19 Is periodontal disease a risk factor for severe COVID-19 illness? Viviana Pitones-Rubio, EG Chávez-Cortez, Angélica Hurtado-Camarena, Anna González-Rascón, Nicolás Serafín-Higuera
333 [GO] 2020―Jun―19 Can COVID-19 induce glioma tumorogenesis through binding cell receptors? Imran Khan, Mustafa Aziz Hatiboglu
334 [GO] 2020―Jun―19 Targeting Adenosinergic Pathway and Adenosine A2A receptor Signaling for the Treatment of COVID-19: A hypothesis Mohamed A. Abouelkhair
335 [GO] 2020―Jun―17 Pirfenidone: A novel hypothetical treatment for COVID-19 Soroush Seifirad
336 [GO] 2020―Jun―17 A physicist's approach to COVID-19 transmission via expiratory droplets Pasquale Carelli
337 [GO] 2020―Jun―16 WHO statement- “Older people are at highest risk from COVID-19”: Should the hypothesis be corroborated or rejected? Ramananda Ningthoujam, Deepa Khomdram
338 [GO] 2020―Jun―15 Microvascular Disease Confers Additional Risk to COVID-19 Infection Bradley Field Bale, Amy Lynn Doneen, David John Vigerust
339 [GO] 2020―Jun―13 A hypothesis about the role of fetal hemoglobin in COVID-19 Ehsan Sotoudeh, Houman Sotoudeh
340 [GO] 2020―Jun―11 Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19 Michal Pruc, Jacek Smereka, Tomasz Dzieciatkowski, Milosz Jaguszewski, Krzysztof J. Filipiak, Lukasz Szarpak
341 [GO] 2020―Jun―10 Endothelial progenitor cells and mesenchymal stem cells to overcome vascular deterioration and cytokine storm in critical patients with COVID-19 Fatih Karaahmet, Sinan Altan Kocaman
342 [GO] 2020―Jun―10 Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy Nehru Sai Suresh Chalichem, Bharathi Bethapudi, Deepak Mundkinajeddu
343 [GO] 2020―Jun―09 Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19 Valente Maldonado, Marco A. Loza-Mejía, Jaime Chávez-Alderete
344 [GO] 2020―Jun―09 Noradrenergic and serotonergic drugs may have opposing effects on COVID-19 cytokine storm and associated psychological effects Paul J. Fitzgerald
345 [GO] 2020―Jun―09 Respiratory droplets get suspended longer and spread wider in temperate environments compared to tropics and implications for SARS-CoV-2 transmission Anusha Rohit, Shankar Rajasekaran, Indrani Karunasagar, Iddya Karunasagar
346 [GO] 2020―Jun―09 Increased susceptibility of SARS-CoV2 infection on Oral Cancer patients; Cause and effects: An Hypothesis Anshika Chauhan, Sushmita Ghoshal, Arnab Pal
347 [GO] 2020―Jun―08 Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy? Aliae A.R. Mohamed-Hussein, Karim M.E. Aly, Mohamed-Eltaher A.A. Ibrahim
348 [GO] 2020―Jun―08 Occult SARS-CoV-2 Infection; A Possible Hypothesis For Viral Relapse Mostafa H. Elberry, Hussien Ahmed
349 [GO] 2020―Jun―07 The intriguing commonality of NETosis between COVID-19 & Periodontal disease Shipra Gupta, Vaibhav Sahni
350 [GO] 2020―Jun―07 Has the chief complaint of patients with COVID-19 disease changed over time? Mohammad Dehghani Firouzabadi, Fatemeh Dehghani Firouzabadi, Sogand Goudarzi, Hesam Jahandideh, Maryam Roomiani
351 [GO] 2020―Jun―07 Burnout syndrome in Romanian medical residents in time of the COVID-19 pandemic Mihai C.T. Dimitriu, Anca Pantea-Stoian, Alexandru C. Smaranda, Anca A. Nica, Alexandru C. Carap, Vlad D. Constantin, et al. (+8)
352 [GO] 2020―Jun―07 Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths? Burak Ozdemir, Ahmet Yazici
353 [GO] 2020―Jun―07 Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy A.P.B. Balaji, Srinivasan Bhuvaneswari, D. Nanda Kumar
354 [GO] 2020―Jun―06 Is Hesperidin Essential for Prophylaxis and Treatment of COVID-19 Infection? Yusuf A. Haggag, Nahla E. El-Ashmawy, Kamal M. Okasha
355 [GO] 2020―Jun―06 A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2? Dan Lipsker
356 [GO] 2020―Jun―05 Intra-abdominal hypertension as a trigger of “gut failure” in SARS-CoV-2 infection: effect of open abdomen (OA) and negative pressure therapy (NPT) on respiratory and gastrointestinal (GI) function Pietro Fransvea, Francesco Santullo, Flavio Tirelli, Valeria Fico, Paolo Mirco, Valerio Cozza, et al. (+2)
357 [GO] 2020―Jun―05 RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection? Mohsen Kerkeni, Jawhar Gharbi
358 [GO] 2020―Jun―02 B-cell engineering: A promising approach towards vaccine development for COVID-19 Muneeb A. Faiq
359 [GO] 2020―Jun―02 Nebulized Lidocaine in COVID-19, An Hypothesis Ziad A. Ali, Rif S. El-Mallakh
360 [GO] 2020―Jun―02 Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly? Irene Lidoriki, Maximos Frountzas, Dimitrios Schizas
361 [GO] 2020―Jun―02 The effects of allium sativum on immunity within the scope of COVID-19 infection Mustafa Metin Donma, Orkide Donma
362 [GO] 2020―Jun―02 Pharmacotherapy for reducing saliva and droplet production in airborne procedures may help to decrease the COVID-19 transmission: a hypothesis Ashkan MohammadSadeghi, Iman Karimzadeh, Kamran Bagheri Lankarani, Morteza Banakar
363 [GO] 2020―Jun―01 The use of aspirated consonants during speech may increase the transmission of COVID-19 Georgios P. Georgiou, Ahmad Kilani
364 [GO] 2020―Jun―01 Diacerein: a potential multi-target therapeutic drug for COVID-19 Pedro Gonçalves de Oliveira, Lara Termini, Edison Luiz Durigon, Ana Paula Lepique, Andrei C Sposito, Enrique Mario Boccardo Pierulivo
365 [GO] 2020―Jun―01 COVID-19 and picotechnology: Potential opportunities Navid Rabiee, Mohammad Rabiee, Mojtaba Bagherzadeh, Nima Rezaei
366 [GO] 2020―Jun―01 Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic Arturo Armone Caruso, Antonio Del Prete, Antonio Ivan Lazzarino
367 [GO] 2020―Jun―01 COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming ? Pierre DENIS
368 [GO] 2020―Jun―01 Fighting against frailty and sarcopenia - As well as COVID-19? Timur Ekiz, Murat Kara, Levent Özçakar
369 [GO] 2020―Jun―01 SARS-CoV-2 and prostatitis: Dangerous relationship for male sexual and reproductive health Walter D. Cardona Maya, Alejandro Carvajal
370 [GO] 2020―May―31 COVID-19 infection: is the outcome time-dependent? Vittorio Pavoni, Lara Gianesello
371 [GO] 2020―May―31 Can hyperimmune anti-CMV globuline substitute for convalescent plasma for treatment of COVID-19? Basic-Jukic Nikolina
372 [GO] 2020―May―30 Antibiotic consumption may be linked to exaggeration of COVID-19 Muhammad Asaduzzaman, Farzana Zaman, Emily Rousham
373 [GO] 2020―May―30 Neutralizing antibodies mediate virus-immune pathology of COVID-19 J.J.L. Jacobs
374 [GO] 2020―May―30 COVID-19 & Periodontitis: The cytokine connection Vaibhav Sahni, Shipra Gupta
375 [GO] 2020―May―30 Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings Dieudonné M. Mvumbi
376 [GO] 2020―May―30 Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: a potential role of cellular FURIN in the pathogenesis of SARS-CoV-2 Kinan Drak Alsibai
377 [GO] 2020―May―30 Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm Saleem Abdulrab, Sadeq Al-maweri, Esam Halboub
378 [GO] 2020―May―30 Are individuals with cardiovascular disease at risk of COVID-19-related mental health problems or individuals with cardiovascular disease at risk of cardiovascular disease-related mental health problems during COVID-19? A Psychological-Psychiatric Perspective Sonia Mukhtar
379 [GO] 2020―May―30 Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal Stelios F. Assimakopoulos, Fotios Seintis, Markos Marangos
380 [GO] 2020―May―30 What would sérgio ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? Lucas A.D. Nicolau, Pedro J.C. Magalhães, Mariana L. Vale
381 [GO] 2020―May―30 Diabetes and severity of COVID-19: What is the link? D. Pitocco, L. Viti, L. Tartaglione, M. Di Leo, G.E. Rizzo, A. Manto, et al. (+3)
382 [GO] 2020―May―30 Could Autism Spectrum Disorders be a Risk Factor for COVID-19? Matheus Eugênio de Sousa Lima, Levi Coelho Maia Barros, Gislei Frota Aragão
383 [GO] 2020―May―30 Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment Marian Rofeal, Fady Abd El-Malek
384 [GO] 2020―May―30 N-Acetylcysteine: a potential therapeutic agent for SARS-CoV-2 Francis L. Poe, Joshua Corn
385 [GO] 2020―May―30 Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: targeting a potential IL-1β/Neutrophil Extracellular Traps feedback loop Ahmed Yaqinuddin, Junaid Kashir
386 [GO] 2020―May―30 Periodontal pockets: A potential reservoir for SARS-CoV-2? Zahi Badran, Alexis Gaudin, Xavier Struillou, Gilles Amador, Assem Soueidan
387 [GO] 2020―May―29 MDA5 should be detected in severe COVID-19 patients Qiang Xu
388 [GO] 2020―May―29 COVID-19: Thinking about further mental and neurological disorders Renato Sobral Monteiro-Junior
389 [GO] 2020―May―29 Persistent SARS-CoV-2 infection and the risk for cancer Miguel Alpalhão, João Augusto Ferreira, Paulo Filipe
390 [GO] 2020―May―28 Could MEFV mutation carriage status have a protective role for COVID-19 pandemia? Salih Kavukçu, Alper Soylu
391 [GO] 2020―May―27 The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast Muhammad Qutayba Almerie, David Daniel Kerrigan
392 [GO] 2020―May―27 Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with 18F-Fluorocholine PET/CT? G. Savelli, M. Bonacina, A. Rizzo, A. Zaniboni
393 [GO] 2020―May―27 Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid Gokhan Unal, Bahadir Turan, Yasin Hasan Balcioglu
394 [GO] 2020―May―27 Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19? Irina Bobkova, Elena Kamyshova, Tatiana Rudenko, Ekaterina Stavrovskaya, Sergey Moiseev
395 [GO] 2020―May―26 Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis Ramachandran Meenakshisundaram, Subramanian Senthilkumaran, Ponniah Thirumalaikolundusubramanian
396 [GO] 2020―May―26 Is anosmia the price to pay in an immune-induced scorched-earth policy against COVID-19? S.D. Le Bon, M. Horoi
397 [GO] 2020―May―25 Potential Role of Zinc Supplementation in Prophylaxis and Treatment of COVID-19 Amit Kumar, Yuichi Kubota, Mikhail Chernov, Hidetoshi Kasuya
398 [GO] 2020―May―25 The Use of Ibuprofen to Treat Fever in COVID-19: A Possible Indirect Association with Worse Outcome? Brenda Jamerson, T. Ho Haryadi
399 [GO] 2020―May―24 Selenium supplementation in the prevention of coronavirus infections (COVID-19) Marek Kieliszek, Boguslaw Lipinski
400 [GO] 2020―May―24 Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19 Subrata K Biswas, Sonchita R Mudi
401 [GO] 2020―May―24 A new pharmacological approach based on remdesivir aerosolized administration on sars-cov-2 pulmonary inflammation: a possible and rational therapeutic application Carlo Contini, Carla Enrica Gallenga, Gianpiero Neri, Martina Maritati, Pio Conti
402 [GO] 2020―May―23 Iodine, a preventive and curative agent in the COVID-19 pandemic? R.H. Verheesen, R.A.M. Traksel
403 [GO] 2020―May―23 Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists M. Allahverdi Khani, M. SalehiRad, S. Darbeheshti, M. Motaghinejad
404 [GO] 2020―May―23 Covid-19: loss of bridging between innate and adaptive immunity? Vishal Rao, Gururaj Arakeri, Anand Subash, Jyothsna Rao, Sachin Jadhav, Mufti Suhail Sayeed, et al. (+2)
405 [GO] 2020―May―23 A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2 Swaroop Revannasiddaiah, Santhosh Kumar Devadas, Rasmi Palassery, Nirdosh Kumar Pant, Vinayak V Maka
406 [GO] 2020―May―23 Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections Ba X Hoang, Huy Q Hoang
407 [GO] 2020―May―22 COVID-19 Cytokine Storm and Novel Truth Sherif Sultan, Mohamed Sultan
408 [GO] 2020―May―22 Three Novel Prevention, Diagnostic and Treatment Options for COVID-19 Urgently Necessitating Controlled Randomized Trials Richard I. Horowitz, Phyllis R. Freeman
409 [GO] 2020―May―22 Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes Mahsa Taghavi-farahabadi, Mohammad Mahmoudi, Sara Soudi, Seyed Mahmoud Hashemi
410 [GO] 2020―May―21 Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19 Giovanni Ponti, Cristel Ruini, Aldo Tomasi
411 [GO] 2020―May―20 Use of Hydroxychloroquine and Interferon alpha-2b for the Prophylaxis of COVID-19 Alexander Yang, Charlotte Yang, Bing Yang
412 [GO] 2020―May―20 Hypoxia Inducible Factor-1 Protects Against COVID-19: A Hypothesis Baris Afsar, Mehmet Kanbay, Rengin Elsurer Afsar
413 [GO] 2020―May―20 Can moderate intensity aerobic exercise be an effective and valuable therapy in preventing and controlling the pandemic of COVID-19? Snehil Dixit
414 [GO] 2020―May―19 Sodium Chromo-Glycate and Palmitoylethanolamide: a Possible Strategy to Treat Mast Cell-induced Lung Inflammation in COVID-19 Antonio Gigante, Alberto Aquili, Luca Farinelli, Alessandro Caraffa, Gianpaolo Ronconi, Carla Enrica Gallenga, et al. (+3)
415 [GO] 2020―May―19 May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions? Claudio Marasca, Angelo Ruggiero, Maddalena Napolitano, Gabriella Fabbrocini, Matteo Megna
416 [GO] 2020―May―19 COVID-19, quarantine, and atopic dermatitis Cataldo Patruno, Steven Paul Nisticò, Gabriella Fabbrocini, Maddalena Napolitano
417 [GO] 2020―May―18 Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19 ? Anuruddha Abeygunasekera, Saroj Jayasinghe
418 [GO] 2020―May―18 Covid-19 disease will cause a global catastrophe in terms of mental health: A hypothesis Delia Izaguirre-Torres, Raúl Siche
419 [GO] 2020―May―16 Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 Farid Dabaghian, Mahnaz Khanavi, Mohammad M. Zarshenas
420 [GO] 2020―May―16 Protective potential of Expectorants against COVID-19 Zohreh Esam
421 [GO] 2020―May―16 The Effect of Potential Therapeutic Agents on QT Interval in Patients with COVID-19 Infection: The Importance of Close Monitoring and Correction of Electrolytes Parham Habibzadeh, Mohsen Moghadami, Kamran Bagheri Lankarani
422 [GO] 2020―May―15 Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection? Jinglu Lyu, Tianyu Miao, Jiajia Dong, Ranran Cao, Yan Li, Qianming Chen
423 [GO] 2020―May―12 Do pets protect their owners in the COVID-19 era? Jan Jurgiel, Krzysztof J. Filipiak, Łukasz Szarpak, Miłosz Jaguszewski, Jacek Smerka, Tomasz Dzieciątkowski
424 [GO] 2020―May―12 Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role Giuseppe Magro
425 [GO] 2020―May―12 Exercise as medicine for COVID-19: An ACE in the hole? Kevin S. Heffernan, Sae Young Jae
426 [GO] 2020―May―12 COVID-19: beta-thalassemia subjects immunised? Edouard Lansiaux, Philippe Pierre Pébaÿ, Jean-Laurent Picard, Joachim Son-Forget
427 [GO] 2020―May―11 As a potential treatment of COVID-19: Montelukast Cihan Fidan, Ayşe Aydoğdu
428 [GO] 2020―May―08 Etoposid-based therapy for severe forms of COVID-19 Kamel Hamizi, Souhila Aouidane, Ghania Belaaloui
429 [GO] 2020―May―07 Covid-19 management with Inflammation Resolving Mediators? Perspectives and Potential Pedro-Antonio Regidor
430 [GO] 2020―May―07 Lithium for the 2019 novel coronavirus Germán Gómez-Bernal
431 [GO] 2020―May―07 What about the original antigenic sin of the humans versus SARS-CoV-2? Luca Roncati, Beniamino Palmieri
432 [GO] 2020―May―06 Genetic predisposition models to COVID-19 infection Farzaneh Darbeheshti, Nima Rezaei
433 [GO] 2020―May―06 Relation between BCG coverage rate and COVID-19 infection worldwide A. Macedo, C. Febra
434 [GO] 2020―May―06 Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19? R. Derwand, M. Scholz
435 [GO] 2020―May―05 Free DNA, a reason for severe COVID-19 infection? Bin Liu
436 [GO] 2020―May―05 Is copper beneficial for COVID-19 patients? Syamal Raha, Rahul Mallick, Sanjay Basak, Asim K. Duttaroy
437 [GO] 2020―May―05 The role of ACEIs/ARBs in COVID-19: friend or foe? Zhe Zhou, Yumin Qiu, Jun Tao
438 [GO] 2020―May―05 Can beta-adrenergic blockers be used in the treatment of COVID-19? Natesan Vasanthakumar
439 [GO] 2020―May―01 COVID-19 AND AUTISM Gary Steinman
440 [GO] 2020―May―01 Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia Rami Bou Khalil
441 [GO] 2020―Apr―29 Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19? Patrizio Tatti, Giancarlo Tonolo, Angela Zanfardino, Dario Iafusco
442 [GO] 2020―Apr―27 Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients Elenice Deffune, Aruã Prudenciatti, Andrei Moroz
443 [GO] 2020―Apr―27 The puzzle of sharing bio-molecular targets between coronaviruses and mediators of the cardiovascular system in humans: Looking for plausible hypotheses Michele M. Ciulla
444 [GO] 2020―Apr―27 Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection A. Klimke, G. Hefner, B. Will, U. Voss
445 [GO] 2020―Apr―27 Why not consider an endothelin receptor antagonist against SARS-CoV-2? S. Javor, A. Salsano
446 [GO] 2020―Apr―25 Amantadine as a drug to mitigate the effects of COVID-19 Gonzalo Emiliano Aranda Abreu, María Elena Hernández Aguilar, Deissy Herrera Covarrubias, Fausto Rojas Durán
447 [GO] 2020―Apr―25 Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19 Junaid Kashir, Ahmed Yaqinuddin
448 [GO] 2020―Apr―25 Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmission G. Correia, L. Rodrigues, M. Gameiro da Silva, T. Gonçalves
449 [GO] 2020―Apr―24 Two simple comments regarding coronavirus Emanuel Gluskin
450 [GO] 2020―Apr―24 Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis? Chenxing Wang, Heming Wu, Xu Ding, Huan Ji, Pengfei Jiao, Haiyang Song, et al. (+2)
451 [GO] 2020―Apr―24 Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2 Pushpendra Mani Mishra, Vladimir N. Uversky, Chayan K. Nandi
452 [GO] 2020―Apr―23 The possible beneficial adjuvant effect of Influenza vaccine to minimize the severity of COVID-19 Mohamed Labib Salem, Dina El-Hennawy
453 [GO] 2020―Apr―23 Potential effect of natural and anabolizan steroids in elderly patient with COVID-19 Fatih Karaahmet, Ozgur Zeliha Karaahmet
454 [GO] 2020―Apr―23 Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 Sai Kiran S.S. Pindiprolu, Sai Harshini Pindiprolu
455 [GO] 2020―Apr―23 Purposing Saikosaponins for the treatment of COVID-19 Eshak I. Bahbah, Ahmed Negida, Mohamed Salah Nabet
456 [GO] 2020―Apr―23 COVID-19 and anosmia in Tehran, Iran Sapideh Gilani, Rachel Roditi, Mohsen Naraghi
457 [GO] 2020―Apr―23 Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS) Eric L. Altschuler, Richard E. Kast
458 [GO] 2020―Apr―23 COVIDiagnosis-Net: Deep Bayes-SqueezeNet based diagnosis of the coronavirus disease 2019 (COVID-19) from X-ray images Ferhat Ucar, Deniz Korkmaz
459 [GO] 2020―Apr―23 2019-nCoV-SARS-CoV-2 (COVID-19) Infectıon: Crucıalıty of Furın and Relevance wıth Cancer Cigdem Usul Afsar
460 [GO] 2020―Apr―23 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection S.I. Ahmad
461 [GO] 2020―Apr―23 Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents Ahmed Yaqinuddin, Junaid Kashir
462 [GO] 2020―Apr―23 Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease Steven R. Brenner
463 [GO] 2020―Apr―23 COVID-19 type III hypersensitivity reaction Batool Mutar Mahdi
464 [GO] 2020―Apr―23 N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome Stelios F. Assimakopoulos, Markos Marangos
465 [GO] 2020―Apr―23 Suggesting Ritonavir against COVID-19/SARS-CoV-2 Shuvasish Choudhury, Muhammed Khairujjaman Mazumder
466 [GO] 2020―Apr―23 Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? Morry Silberstein
467 [GO] 2020―Apr―23 Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids M.D. Maurizio Coppola, M.D. Raffaella Mondola
468 [GO] 2020―Apr―23 A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: potential implications for the SARS-CoV-2 modus operandi George D. Vavougios
469 [GO] 2020―Apr―22 Dapsone and doxycycline could be potential treatment modalities for COVID-19 Ahmed Farouk, Samar Salman
470 [GO] 2020―Apr―22 Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality Mark R. Geier, David A. Geier
471 [GO] 2020―Apr―22 May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications? Jan Adamowicz, Kajetan Juszczak, Tomasz Drewa
472 [GO] 2020―Apr―22 Hypothesized behavioral host manipulation by SARS-CoV2 / COVID-19 infection Michael C. Barton, Kaylee V. Bennett, John R. Cook, Gordon G. Gallup, Steven M. Platek
473 [GO] 2020―Apr―22 May IL-17 have a role in COVID-19 infection? Matteo Megna, Maddalena Napolitano, Gabriella Fabbrocini
474 [GO] 2020―Apr―22 Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria? Gokhan Sargin, Sare İlknur Yavaşoğlu, Irfan Yavasoglu
475 [GO] 2020―Apr―22 The Powerful Immune System Against Powerful COVID-19: A Hypothesis Farzad Taghizadeh-Hesary, Hassan Akbari
476 [GO] 2020―Apr―22 Can pioglitazone be potentially useful therapeutically in treating patients with covid-19? Elena Carboni, Anna R. Carta, Ezio Carboni
477 [GO] 2020―Apr―20 The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? F.B. Belen-Apak, F. Sarialioglu
478 [GO] 2020―Apr―06 WITHDRAWN: Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic? Mayda Gursel, Ihsan Gursel
479 [GO] 2020―Mar―26 Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms Ioannis Ilias, Lina Zabuliene
480 [GO] 2020―Mar―25 Routine childhood immunization may protect against COVID-19 Samar Salman, Mohamed Labib Salem
481 [GO] 2020―Mar―21 Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2 Luca Roncati, Graziana Gallo, Antonio Manenti, Beniamino Palmieri

481 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.010 sec